XPH Holdings — SPDR(R) S&P(R) Pharmaceuticals ETF
All 62 reported holdings of SPDR(R) S&P(R) Pharmaceuticals ETF (XPH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| State Street Global Advisors | 7.93% | $24.40M |
| Enliven Therapeutics Inc | 2.45% | $7.54M |
| Corcept Therapeutics Inc | 2.29% | $7.05M |
| Terns Pharmaceuticals Inc | 2.16% | $6.65M |
| Perrigo Co PLC | 2.10% | $6.46M |
| Axsome Therapeutics Inc | 2.03% | $6.26M |
| Innoviva Inc | 1.99% | $6.14M |
| Merck & Co Inc | 1.98% | $6.11M |
| Pfizer Inc | 1.97% | $6.07M |
| Royalty Pharma PLC | 1.97% | $6.07M |
| Elanco Animal Health Inc | 1.96% | $6.02M |
| Jazz Pharmaceuticals PLC | 1.96% | $6.02M |
| Esperion Therapeutics Inc | 1.95% | $6.01M |
| Edgewise Therapeutics Inc | 1.95% | $6.00M |
| MBX Biosciences Inc | 1.95% | $5.99M |
| Definium Therapeutics Inc | 1.95% | $5.99M |
| Bristol-Myers Squibb Co | 1.94% | $5.97M |
| ANI Pharmaceuticals Inc | 1.93% | $5.95M |
| Johnson & Johnson | 1.93% | $5.94M |
| Tarsus Pharmaceuticals Inc | 1.93% | $5.93M |
| Trevi Therapeutics Inc | 1.92% | $5.90M |
| Pacira BioSciences Inc | 1.90% | $5.84M |
| Zoetis Inc | 1.89% | $5.83M |
| Crinetics Pharmaceuticals Inc | 1.88% | $5.80M |
| Nektar Therapeutics | 1.88% | $5.79M |
| Liquidia Corp | 1.88% | $5.78M |
| Amneal Pharmaceuticals Inc | 1.88% | $5.77M |
| Harmony Biosciences Holdings Inc | 1.87% | $5.74M |
| Supernus Pharmaceuticals Inc | 1.86% | $5.73M |
| Viatris Inc | 1.85% | $5.71M |
| Xeris Biopharma Holdings Inc | 1.84% | $5.66M |
| Harrow Inc | 1.83% | $5.64M |
| Organon & Co | 1.79% | $5.53M |
| Nuvation Bio Inc | 1.79% | $5.52M |
| Phibro Animal Health Corp | 1.79% | $5.51M |
| Amylyx Pharmaceuticals Inc | 1.79% | $5.50M |
| Indivior Pharmaceuticals Inc | 1.78% | $5.48M |
| Collegium Pharmaceutical Inc | 1.78% | $5.48M |
| Eli Lilly & Co | 1.76% | $5.43M |
| Prestige Consumer Healthcare Inc | 1.75% | $5.40M |
| Ligand Pharmaceuticals Inc | 1.73% | $5.33M |
| Ocular Therapeutix Inc | 1.71% | $5.26M |
| Omeros Corp | 1.70% | $5.23M |
| EyePoint Inc | 1.66% | $5.10M |
| Alumis Inc | 1.60% | $4.94M |
| Amphastar Pharmaceuticals Inc | 1.45% | $4.46M |
| Phathom Pharmaceuticals Inc | 1.44% | $4.43M |
| Theravance Biopharma Inc | 1.42% | $4.36M |
| Rapport Therapeutics Inc | 1.37% | $4.21M |
| Arvinas Inc | 1.25% | $3.84M |
| CorMedix Inc | 1.22% | $3.76M |
| BioAge Labs Inc | 1.20% | $3.69M |
| Maze Therapeutics Inc | 1.13% | $3.49M |
| Septerna Inc | 1.00% | $3.09M |
| WaVe Life Sciences Ltd | 0.99% | $3.04M |
| Zevra Therapeutics Inc | 0.98% | $3.03M |
| Fulcrum Therapeutics Inc | 0.92% | $2.82M |
| Aquestive Therapeutics Inc | 0.81% | $2.49M |
| LB Pharmaceuticals Inc | 0.71% | $2.20M |
| Alto Neuroscience Inc | 0.54% | $1.65M |
| State Street Global Advisors | 0.08% | $257.20K |
| State Street Global Advisors | 0.00% | $5.48K |